Zota Health Care LImited

Healthcare

NSE: ZOTA
₹1294.70
▼ -5.50 (-0.42%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
—/100
Data unavailable
Valuation
—/100
Data unavailable
Momentum
70/100
Bullish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
14.67%
FII + DII, latest filed period
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
-4.0
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
₹-84 Cr
as of March 31, 2026
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 2 met
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Value and momentum

2 of 4 met
  • Yes Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-0.4%
Low 1276.0000 · High 1331.7000
1W return
-6.9%
Low 1276.0000 · High 1405.8000
1M return
22.9%
Low 1022.0000 · High 1438.0000
52W return
-10.0%
Low 1022.0000 · High 1740.0000
Lifetime High ₹1687.0000 (Dec. 15, 2025)
Lifetime Low ₹125.6000 (May 10, 2017)

Full price history and technicals →

EMA & SMA

Bullish5
Bearish1
5D
1306.6
10D
1280.1
20D
1232.6
50D
1212.9
100D
1235.4
200D
1280.2

Delivery and volume

Day avg. delivery
81.7%
Week avg. delivery
70.5%
Month avg. delivery
42.5%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

1300.80
Pivot
First resistance1325.60
Second resistance1356.50
Third resistance1381.30
First support1269.90
Second support1245.10
Third support1214.20
Day RSI60.8
Day MFI84.9
Day MACD48.17
Day MACD signal29.95

Beta

1M1.65
3M0.30
1Y1.14
3Y1.05

Price change analysis

↑ 22.9%
Over 1 Month
LowHigh
1022.001438.00
↓ -9.5%
Over 3 Months
LowHigh
1022.001478.00
↑ 16.0%
Over 6 Months
LowHigh
1022.001478.00
↓ -10.0%
Over 1 Year
LowHigh
1022.001740.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹127 Cr
Net profit (June 30, 2026)
₹2 Cr
Basic EPS (June 30, 2026)
₹

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter49.38%
  • Mutual funds0.37%
  • FII/FPI7.92%
  • Other DII6.38%
  • Public35.95%

Largest holders

NameCategoryShares %Shares
HIMANSUBHAI MUKTILAL ZOTAPromoter9.0500%3135580
KETANKUMAR CHANDULAL ZOTAPromoter8.8100%3051363
MANUKANT CHANDULAL ZOTAPromoter6.2700%2172070
KAMLESH RAJANIKANT ZOTAPromoter5.7500%1991103
ASHA MUKUL AGRAWALPublic5.1400%1780000

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 49.38% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 8.21% to 7.92% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 0.37% in Jun 2026 qtr

All shareholding details →

Insider trading, SAST & pledges

All 76 insider trades, 28 SAST, 9 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
6 Oct 2025 VINODCHANDRA DHIRAJLAL MEHTA Promoter group Sell 0 ₹0
7 Jul 2025 BHIKHALAL CHHOTALAL DOSHI Promoter group Buy 0 ₹0
25 Jun 2025 NIRMALABEN A SHAH Promoter group Sell 0 ₹0
18 Mar 2025 KENVI ZOTA Promoter group Buy 0 ₹0
18 Mar 2025 HIMANSHU MUKTILAL ZOTA Promoter Sell 0 ₹0
24 Dec 2024 NIRUBEN VINODKUMAR MEHTA Promoter group Sell 0 ₹0
24 Dec 2024 VINODCHANDRA DHIRAJLAL MEHTA Promoter group Buy 0 ₹0
24 Dec 2024 VINODCHANDRA DHIRAJLAL MEHTA Promoter group Sell 0 ₹0
23 Aug 2024 MANUKANT CHANDULAL ZOTA Promoter Sell 0 ₹0
23 Aug 2024 NIRMALABEN A SHAH Promoter group Buy 0 ₹0

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
23 Dec 2022 BARCLAYS SECURITIES INDIA PRIVATE LIMITED Bulk Sell 213,033 254.5000 NSE
3 Aug 2021 MUDUPULAVEMULA SURENDRANADHA REDDY Bulk Sell 267,969 358.5900 NSE
3 Aug 2021 MUDUPULAVEMULA SURENDRANADHA REDDY Bulk Buy 27,669 333.4500 NSE
15 Apr 2021 MINESH JORMALBHAI MEHTA Bulk Sell 1,150,144 145.1500 NSE
15 Apr 2021 M/S. PRARTHANA ENTERPRISES Bulk Buy 1,150,144 145.1500 NSE
31 May 2017 ANAL MILAN PARIKH Bulk Buy 105,000 133.3400 NSE
23 May 2017 PARIKH NIRMALABEN SURESHBHAI Bulk Buy 112,000 129.0000 NSE
18 May 2017 PARIKH NIRMALABEN SURESHBHAI Bulk Buy 93,000 131.6500 NSE
16 May 2017 MINESH JORMALBHAI MEHTA Bulk Buy 134,000 128.6000 NSE
10 May 2017 RAJEEV SUBHASH CHAND MAHESHWARI Bulk Buy 193,000 129.1800 NSE

All bulk and block deals →

Last 12 months ₹1.00 per share
Dividend yield 0.08%
Ex-dateSubjectPer share (₹)Record date
21 Sep 2026 Dividend - Re 1 Per Share 1.0000 21 Sep 2026
22 Sep 2025 Dividend - Re 1 Per Share 1.0000 22 Sep 2025
20 Sep 2024 Annual General Meeting/Dividend - Re 1 Per Share 1.0000 21 Sep 2024
22 Sep 2023 Annual General Meeting/Dividend - Re 1 Per Share 1.0000 —
19 Sep 2022 Annual General Meeting/Dividend - Rs 1.50 Per Share 1.5000 —
22 Sep 2021 Annual General Meeting/ Dividend Rs 1 Per Share 1.0000 —
17 Sep 2020 Annual General Meeting/Dividend - Re 1 Per Share 1.0000 —
12 Sep 2019 Annual General Meeting/Dividend - Re 1 Per Share 1.0000 —

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
13 Aug 2026 Financial Results/Other business matters Yes
22 May 2026 Financial Results/Dividend/Other business matters Yes
4 Feb 2026 Financial Results/Other business matters Yes
17 Oct 2025 Financial Results/Other business matters Yes
4 Sep 2025 Fund Raising/Other business matters —

Corporate Announcements

All 794 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 General Updates Zota Health Care Limited has informed the Exchange about Davaindia Stores Update for Q2FY27
1 Oct 2026 Acquisition ZOTA: Zota Health Care Limited has informed the Exchange about Acquisition of 39,228 equity shares of M/s Davaindia Health Mart Limited, Wholly Owned Subsidiary of the Company, by way of subscription to the right issue.
1 Oct 2026 Acquisition ZOTA: Zota Health Care Limited has informed the Exchange about Acquisition of 21,00,000 equity shares of M/s KMHP Ventures Limited, Wholly Owned Subsidiary of the Company, by way of subscription to the right issue
1 Oct 2026 Acquisition ZOTA: Zota Health Care Limited has informed the Exchange about Acquisition of 20,20,000 equity shares of M/s Curexis Ventures Private Limited, Wholly Owned Subsidiary of the Company, by way of subscription to the right issue.
30 Sep 2026 Shareholders meeting ZOTA: Zota Health Care Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 28, 2026. Further, the company has informed the Exchange regarding voting results.
28 Sep 2026 Trading Window Zota Health Care LImited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
28 Sep 2026 Shareholders meeting ZOTA: Zota Health Care Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 28, 2026.
24 Sep 2026 General Updates Zota Health Care Limited has informed the Exchange about Communication to Shareholders - Intimation w.r.t Tax Deduction on Dividend.
21 Sep 2026 Updates Zota Health Care Limited has informed the Exchange regarding 'Annual General Meeting Notice Response to Proxy Advisory Firm'.
18 Sep 2026 Cessation Zota Health Care Limited has informed the Exchange regarding Cessation of Mrs Varshabahen Gaurang Mehta as Non- Executive Independent Director of the company w.e.f. September 09, 2026, upon completion of her tenure.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Zota Health Care LImited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.